THC, the main psychoactive compound in cannabis, produces a high by hijacking a signaling system your brain already uses. Your neurons communicate partly through molecules called endocannabinoids, and THC happens to fit into the same receptors those molecules use. When THC locks onto CB1 receptors scattered across your brain, it disrupts the normal flow of signals between neurons, altering everything from mood and memory to your sense of time and appetite. The specifics of how that plays out depend on where in the brain those receptors sit, how many of them THC activates, and your own biology.
Your Brain Already Runs on Cannabis-Like Chemicals
Long before anyone smoked a joint, your brain was producing its own cannabis-like molecules. The two best-studied are anandamide and 2-AG, and they serve as a kind of volume knob for neural communication. When a neuron fires too rapidly or too strongly, it triggers the release of these endocannabinoids from the receiving cell, which travel backward to the sending cell and tell it to quiet down. This “retrograde signaling” keeps neural circuits from overexciting themselves. The system is ancient: endocannabinoid signaling has been found in organisms ranging from leeches to humans, and even in creatures as simple as the hydra, though insects appear to lack it entirely.1PubMed Central. The evolution and comparative neurobiology of endocannabinoid signalling2PubMed Central. The Endocannabinoid System of Animals
The receptor THC primarily targets is the CB1 receptor, and these receptors are not evenly spread across the brain. They show up at their highest densities in areas involved in memory formation, emotional processing, and higher-order thinking. Mapping studies of the human brain have found very high concentrations of CB1 receptors in the hippocampus (crucial for forming new memories), the amygdala (involved in fear and emotional responses), and the associational regions of the frontal and temporal lobes, which handle complex thought and decision-making. Primary sensory and motor areas have comparatively lower densities.3Neuroscience. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain This map of receptor density is essentially a map of the high itself: the brain regions with the most CB1 receptors are the ones most affected when THC floods the system.
An important detail about these receptors is that they sit more heavily on inhibitory neurons than on excitatory ones. Research across human and primate brains has shown significantly higher CB1 receptor levels on inhibitory nerve terminals compared to excitatory ones in every cortical region examined.4Scientific Reports. Cell type specific cannabinoid CB1 receptor distribution across the human and non-human primate cortex This matters because when THC dials down the activity of inhibitory neurons, the excitatory neurons they were keeping in check can fire more freely. The result is a kind of chaotic loosening of neural circuits, which contributes to the altered thinking, heightened sensory experiences, and sometimes anxiety that come with being high.
THC Is a Partial Agonist, and That Matters
THC does not slam CB1 receptors the way your own endocannabinoids do. It is what pharmacologists call a partial agonist: it activates the receptor, but only partway. When THC binds, it triggers a partial shift in the receptor’s internal structure, enough to produce a signal but not the full response a complete agonist would generate.5PubMed Central. Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors6iScience. Why Does Weed Make You High: How THC Affects Your Brain
This partial activation is actually a big part of why cannabis produces the effects it does rather than something more extreme. Synthetic cannabinoids (the chemicals in products sometimes sold as “spice” or “K2”) are often full agonists at CB1, meaning they crank the receptor to maximum. That is a major reason those substances are far more dangerous and unpredictable than plant-derived cannabis. THC’s partial agonism creates a ceiling on how strongly it can activate any given receptor, which limits the intensity of its effects even at high doses. You still get high, but the system has a built-in brake that full agonists bypass.
Your own endocannabinoids, like 2-AG, are also cleared from the synapse quickly by enzymes that break them down. THC, by contrast, lingers. It is not broken down by the same enzymes at the same speed, so it keeps nudging those receptors for much longer than your body’s own signals would. That extended presence is part of what turns a brief, precisely timed natural signal into the sustained, diffuse alteration in brain function that we experience as being high.
Why It Feels Good: THC and the Reward System
One of the most prominent effects of cannabis is the sense of pleasure and relaxation, and that traces directly to THC’s impact on dopamine. When THC activates CB1 receptors in the brain’s mesolimbic pathway (the circuitry connecting the midbrain to reward-processing areas), it triggers a surge of dopamine release. This is the same reward circuit activated by every known drug of abuse, and cannabis is no exception: despite a common belief that cannabis is somehow unique or gentler in this regard, it exerts effects on mesolimbic dopamine transmission that are fundamentally the same as those of other addictive substances.7PubMed Central. A brain on cannabinoids: the role of dopamine release in reward seeking
The flip side is also consistent with other drugs: during cannabis withdrawal, dopamine transmission in this same circuit drops below normal baseline. That dip contributes to the irritability, restlessness, and reduced motivation that regular users sometimes report when they stop. The effect is milder than what happens with substances like cocaine or opioids, which produce far sharper dopamine spikes and crashes, but the underlying mechanism is the same.
Memory Disruption and the Hippocampus
If you have ever been high and walked into a room only to forget why you went there, you have experienced THC’s effect on the hippocampus firsthand. The hippocampus is densely packed with CB1 receptors, and when THC floods them, the ability to form and retrieve short-term memories takes a direct hit. Animal studies have cleanly demonstrated this: when researchers gave rats THC and then tested them on maze tasks that require remembering which arms they had already visited, the animals made significantly more errors. Crucially, when researchers also gave a drug that blocks CB1 receptors specifically in the hippocampus, the memory impairment vanished, confirming that the effect depends on CB1 activation in that particular brain region.8PubMed Central. Hippocampal CB1 receptors mediate the memory impairing effects of Δ9-tetrahydrocannabinol
The molecular picture is getting clearer too. In mice, THC has been shown to impair short-term object-recognition memory through a specific signaling pathway involving protein kinase C. Block that pathway and the memory impairment is reduced, which helps explain why the memory disruption is specific to certain types of recall rather than a general cognitive shutdown.9PubMed Central. Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol
Warped Time, Heightened Senses, and Paranoia
Most cannabis users report that time seems to slow down while they are high. This is not just anecdotal: controlled studies using intravenous THC at different doses have found that higher doses produce significant overestimation of how much time has passed. In time-estimation tasks, people given high-dose THC thought more time had elapsed than actually did, and in time-production tasks, they underproduced intervals, behaving as though a given duration was longer than it really was.10PubMed Central. Acute Effects of THC on Time Perception in Frequent and Infrequent Cannabis Users The effect was dose-dependent: higher doses produced greater distortion. The brain regions responsible for time perception overlap with areas rich in CB1 receptors, including the prefrontal cortex and basal ganglia, so the distortion makes sense anatomically.
Heightened sensory experiences, including the intensified taste and enjoyment of food (the “munchies”), are another hallmark. Survey research on cannabis users found that the eating experience under cannabis influence breaks down into two distinct dimensions: a hedonic component involving enhanced enjoyment and altered sensory perception of food, and an appetitive component involving increased motivation to eat.11PubMed. Exploring the munchies: An online survey of users’ experiences of cannabis effects on appetite and the development of a Cannabinoid Eating Experience Questionnaire In other words, food does not just taste better when you are high; your brain is also more driven to seek it out. CB1 receptors in the hypothalamus and olfactory regions appear to drive this dual effect.
Then there is paranoia, the less pleasant side of THC’s effects. A rigorous study using intravenous THC found that the drug significantly increased paranoia compared to placebo. The researchers investigated what cognitive mechanisms might explain this and found that the paranoia was fully accounted for by THC-induced anomalous experiences and negative emotional states. Working memory impairment, on the other hand, did not seem to drive the paranoia.12PubMed Central. How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia That means the paranoid feelings are not just a side effect of being confused or forgetful; they come from THC directly altering emotional processing and causing experiences to feel strange or threatening.
Impaired Coordination and the Cerebellum
Cannabis users commonly notice clumsiness, slower reaction times, and difficulty with fine motor tasks. CB1 receptors are abundant in the cerebellum, the brain region that coordinates movement and motor learning, and in the cortico-striatal networks that connect the cortex to deeper motor-control structures. THC’s activation of these receptors disrupts the precise timing that smooth movement depends on.13PubMed Central. Cognitive motor deficits in cannabis users
With chronic use, the picture changes in a worrying way. Long-term cannabis use leads to downregulation of CB1 receptors in the cerebellum, and this appears to impair the cerebellum’s ability to process sensory errors, the mechanism by which the brain corrects and refines movements over time. Researchers have found that a cerebellar-dependent motor learning task can reliably distinguish chronic cannabis users from non-users, suggesting that the damage to this system is not just acute impairment but a lasting disruption of motor adaptation.14Addictive Behaviors. Chronic use of cannabis might impair sensory error processing in the cerebellum through endocannabinoid dysregulation
How THC Moves Through Your Body
The route of administration shapes the high considerably. When you smoke or vape cannabis, THC enters the bloodstream through the lungs almost immediately, reaching peak blood levels within minutes. The high comes on fast and begins to fade within an hour or two. Eating cannabis is a different experience. The THC passes through your digestive system and liver, where enzymes convert a significant portion of it into 11-hydroxy-THC, a metabolite that is itself psychoactive and crosses into the brain more readily than THC does. Pharmacokinetic studies have shown that during oral dosing, free 11-hydroxy-THC and the inactive metabolite THCCOOH climb steadily, while THC itself does not accumulate in the same way.15PubMed Central. Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC This is why edibles tend to produce a more intense, longer-lasting, and sometimes disorienting high compared to smoking: you are getting a different mix of psychoactive molecules.
THC is also fat-soluble, meaning it accumulates in your body’s fat tissue and can linger there for weeks after your last use.16PubMed Central. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure Small amounts of stored THC can be re-released into the bloodstream during periods of stress or fasting, when the body breaks down fat stores. Whether these re-released amounts are large enough to produce noticeable psychoactive effects in humans is debated, but they are enough to cause positive drug tests long after someone last used cannabis.
Why Tolerance Builds and Why It Reverses
Regular cannabis users need more to achieve the same high, and the mechanism behind this is now well understood. Chronic exposure to THC causes the brain to physically reduce the number of CB1 receptors available on neuronal surfaces, a process called downregulation. Brain imaging studies of chronic daily cannabis smokers have confirmed substantial downregulation of CB1 receptors, with the degree of reduction varying by brain region.17PubMed Central. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers Fewer receptors means each dose of THC activates fewer targets, so the effects are dulled.
The good news for anyone considering a break: this process is reversible. The same imaging studies found that CB1 receptor levels began recovering after about four weeks of abstinence. At the molecular level, recent research has identified a specific pathway through which this downregulation occurs. Prolonged CB1 receptor activation triggers a protein called NEDD4L to tag the receptor for destruction by the cell’s waste-disposal machinery.18PubMed Central. Cannabinoid tolerance relies on CB(1) receptor ubiquitination by NEDD4L Understanding this mechanism could eventually lead to ways of managing tolerance in patients who use medical cannabis, for whom escalating doses become a real clinical problem.
How CBD Changes the Picture
Cannabidiol (CBD), the other major compound in cannabis, does not produce a high on its own. But it does interact with the same CB1 receptor that THC targets, just in a very different way. CBD acts as a negative allosteric modulator of CB1, meaning it binds to a different spot on the receptor and changes its shape so that THC (or any other molecule sitting in the main binding site) has a harder time fully activating it.19PubMed Central. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor20PubMed Central. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons In practical terms, CBD can dampen some of THC’s effects. This is consistent with user reports that cannabis strains high in CBD tend to produce a less anxious, less intensely psychoactive experience than those with THC alone.
Cannabis also contains dozens of aromatic compounds called terpenes, and some proponents claim these contribute to the high through an “entourage effect.” The evidence for this is thin, at least when it comes to direct CB1 receptor activity. Laboratory testing of common cannabis terpenes at relevant concentrations found that none of them significantly altered binding at CB1, and only one (beta-caryophyllene) had a modest effect at CB2.21Frontiers in Pharmacology. Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors That does not rule out terpenes affecting the experience through other pathways (some are known to interact with serotonin or GABA receptors), but the popular idea that they meaningfully amplify THC’s effect at cannabinoid receptors has not held up.
Genetic Variation and Vulnerability to Psychosis
Not everyone responds to THC the same way, and genetics play a measurable role in determining who experiences the worst outcomes. Research has converged on the gene AKT1, which encodes a protein involved in dopamine signaling. People who carry two copies of a particular variant (the C/C genotype at rs2494732) appear significantly more vulnerable to psychotic reactions from cannabis. One study found that cannabis users with this C/C genotype had more than double the odds of developing a psychotic disorder compared to users who carried the T/T genotype. Among daily users, the difference was stark: C/C carriers had roughly seven times the odds of psychosis compared to T/T carriers.22Biological Psychiatry. Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users
A separate study confirmed that among people who already had psychotic disorders, those with the C/C genotype who used cannabis before illness onset showed slower reaction times and lower accuracy on cognitive tasks, while T/T carriers who used cannabis performed similarly to or better than non-using patients.23PubMed Central. AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder AKT1 is not the only gene involved. Variants in CNR1, the gene that encodes the CB1 receptor itself, have also been linked to psychosis risk in combination with cannabis use, pointing to a picture where multiple genetic factors shape individual vulnerability.24PubMed Central. Lifetime cannabis use and childhood trauma increase risk of psychosis in carriers of CNR1 genetic variants: findings from the STREAM study
Genetic testing for these variants is not standard practice, and knowing your genotype would not give you a definitive answer about your personal risk. But this research does explain why cannabis can be benign for one person and genuinely destabilizing for another, even at the same dose and frequency. The popular notion that cannabis is universally safe because “it’s natural” misses the reality that its effects are filtered through individual neurobiology.
Endocannabinoid Tone and Why Responses Change With Age
Your baseline endocannabinoid levels are not fixed. They fluctuate with stress, sleep, exercise, and age. Recent research measuring blood levels of endocannabinoids across different age groups found that older adults tended to have lower baseline levels of anandamide and related compounds compared to younger adults. After recent cannabis use, those age-related differences largely disappeared, with older adults showing larger increases in anandamide and related lipids than younger adults did.25Scientific Reports. Age differences in endocannabinoid tone are ameliorated after recent cannabis use
This is an early finding, but it suggests that the subjective experience of cannabis could shift meaningfully over a person’s lifetime, not just because of changes in tolerance or context, but because the underlying endocannabinoid system itself changes. Someone who used cannabis comfortably in their twenties might find it hits differently in their fifties, and that shift may have a biochemical basis beyond simple changes in body fat or metabolism. The field is still working this out, but it adds another layer to the increasingly clear picture that the question “why does weed make you high” never has a single universal answer. The high is always a conversation between THC and whatever version of the endocannabinoid system you happen to bring to the encounter.